Chinese biotech deal making is moving beyond the licensing of individual drug candidates, as the country transforms from a follower…
Read More
Chinese AI drug researcher XtalPi expects to turn first annual profit on 193% revenue jump
Chinese artificial intelligence-powered drug researcher XtalPi Holdings said it expects to turn its first annual profit on the back of…
Read More
Capital injection: China backs AI drug makers in self-reliance drive
Hangzhou-based METiS TechBio, founded in 2020, raised 400 million yuan (US$57.9 million) in series D financing in August last year,…
Read More
MindRank in Phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it China’s first artificial…
Read More
Chinese drug makers put on brave face after report says Trump mulling curbs on US licensing
Chinese drug makers put on a brave face in the wake of a report that said the Trump administration was…
Read More
AI for science, drug discovery to have ‘greatest impact’, says Nvidia’s Huang
The use of artificial intelligence for science would have an even bigger impact than its use for human-related tasks, Nvidia…
Read More
Hong Kong start-up IntelliGen AI aims to challenge Google DeepMind in drug discovery
IntelliGen AI, an artificial intelligence (AI) start-up founded in Hong Kong, is positioning itself as a competitor to Google DeepMind…
Read More
AI-driven drug discovery aided by Greater Bay Area integration, Hong Kong-listed firm says
XtalPi Holdings, an artificial intelligence (AI) drug discovery firm based in the Greater Bay Area, is changing the biopharmaceutical industry…
Read More
Generative AI helps Hong Kong’s Insilico Medicine design potential new IBD drug
Hong Kong-based Insilico Medicine said its generative artificial intelligence (AI) platforms helped it design a molecule that showed promise in…
Read More